Benitec Biopharma (BNTC) Other Operating Expenses (2019 - 2024)
Benitec Biopharma (BNTC) posted Other Operating Expenses of -$3000.0 for Q1 2024, down 400.0% sequentially from $1000.0 in Q4 2023.
Benitec Biopharma (BNTC) Other Operating Expenses (2019 - 2024) Analysis & Trends
Benitec Biopharma has reported Other Operating Expenses for 6 years, with the latest figure at -$3000.0 in Q1 2024.
- Quarterly Other Operating Expenses changed N/A year-over-year to -$3000.0 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was -$3000.0 (up 97.14% YoY) and the FY2024 annual result came in at -$108000.0, changed N/A from the prior year.
- Other Operating Expenses slipped to -$3000.0 in Q1 2024 per BNTC's latest filing, from $1000.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $134000.0 in Q3 2020 and troughed at -$106000.0 in Q3 2023.
- A 5-year average of $11900.0 and a median of $4000.0 in 2021 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2021 and 2022: Other Operating Expenses slumped 97.92% in 2021, then jumped 800.0% in 2022.
- Over 5 years, Other Operating Expenses stood at -$19000.0 in 2020, then jumped by 105.26% to $1000.0 in 2021, then surged by 800.0% to $9000.0 in 2022, then plunged by 88.89% to $1000.0 in 2023, then plunged by 400.0% to -$3000.0 in 2024.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$3000.0, $1000.0, and -$106000.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -3,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | -106,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 7,000.00 |
| Dec 31, 2020 | -19,000.00 |
| Sep 30, 2020 | 134,000.00 |
| Jun 30, 2020 | 48,000.00 |
| Mar 31, 2020 | 47,000.00 |
| Dec 31, 2019 | -306,000.00 |
| Sep 30, 2019 | 26,000.00 |